• Brand Name: Axishil
  • International: Inlyta
  • Medicine Name: Axitinib
  • Company Name: Shilpa Medicare
  • Pack Size: 14 Tablets
  • Strenght- 1 mg and 5 mg
Get Price
Categories: ,


General Warning: Axitinib can cause bleeding which can be serious. Call your doctor right away or seek medical help if you develop signs or symptoms of unexpected bleeding or bleeding that lasts a long time such as unusual bleeding from the gums, red or black stools, menstrual bleeding or vaginal bleeding, pink or brown urine and cough up blood or blood clots.

Axitinib uses:

Axitinib belongs to targeted therapy. It is a receptor protein kinase inhibitor and prescription medication recommended in order to treat advanced kidney cancer (advanced renal cell carcinoma or RCC) when one prior drug treatment regimen for your RCC has not worked.

Axitinib side effects:

The most common side effects of axitinib tablets are reported as follows:

  • diarrhea (frequent or loose bowel movements)
  • Tiredness or feeling weak
  • decreased appetite
  • nausea
  • hoarseness
  • rash
  • itching
  • decreased weight
  • vomiting
  • Constipation

Dosage: The initial dose is axitinib 5 mg orally twice daily. Dose adjustments should be made on behalf of individual safety as well as tolerability. Administer axitinib dose about 12 hours apart with or without food. The axitinib should be swallowed whole with the glass of water.


  • Your healthcare professional should check your urine for protein prior to and during your treatment with the axitinib 1mg.
  • Avoid drinking grapefruit juice or eat grapefruit. Grapefruit can be responsible for increasing the amount of this drug in your blood.
  • Effective birth control should be used during treatment and for at least 7 days after your last dose of axitinib.
  • If your female partner becomes pregnant during your treatment with the axitinib, inform your doctor right away.
  • This medication shouldn’t be recommended if you are breastfeeding or plan to breastfeed.
  • Prior to initiating treatment with this dug, female patients should tell their healthcare provider if they are pregnant or plan to become pregnant.
  • If you are carrying a plan to have surgery or have had a recent surgery. You must stop consuming this drug for at least 2 days prior to planned surgery.

More Info.

Drugs Approved for Kidney (Renal Cell) Cancer

  • Afinitor (Everolimus)
  • Afinitor Disperz (Everolimus)
  • Aldesleukin.
  • SORANIB™ (Sorafenib 200 mg )
  • Avelumab.
  • SORAFENAT™ (Sorafenib 200mg )
  • Bavencio (Avelumab)
  • Bevacizumab.
  • NUBLEXA (Regorafenib)
  • Prograf (Tacrolimus Ointment 0.1)

Interactions: Use together with the strong CYP3A4/CYP3A5 inhibitors need to be avoided where possible as they may involve in reducing the plasma clearance of axitinib.

Overdose: If you take too much axitinib, call your healthcare provider or immediately head towards the nearest hospital emergency room.

Missed Dose: If you vomit or miss a dose of axitinib, consume your next dose at about your regular time. Avoid the consumption of two axitinib doses at the same time.

Commonly Asked Questions

What is the best price for axitinib?

Please contact at the Toll-free number +91 1800 889 1064 (8130290915) for Axitinib price in India. Email – We help by providing the assurance of quality as well as delivery across the world as per the buyer’s requirements.

Where can I buy axitinib?

The Indian Pharma connects buyer’s with the supplier who can ship Axitinib to any country of the world as per the buyer’s requirement and Government regulations of the country. The company has options in order to choose the exporter and supplier of cancer treatment medications. The Indian Pharma provides a guarantee of the quality as well as delivery across the world as per the need of buyers.

How does an order will be confirmed?

The order of Axitinib fda label drug can only be placed after the receipt of:

  • Valid prescription of a doctor
  • Import permit (if required)

Axitinib cost: Axitinib is a cost-friendly and inexpensive medicine that is available at all the legitimate pharmaceutical companies. It exists at the Indian pharma with the availability of worldwide shipping.

What is renal cell carcinoma?

Renal cell carcinoma (hypernephroma, adenocarcinoma of renal cells) basically is the most common malignant kidney cancer, accounting for around 90 % of kidney cancers. RCC is considered a “silent cancer” because its symptoms don’t typically get noticed until the tumor has grown pretty large.

Conclusion: Axitinib has a quite well-established role for managing the mRCC. Compared to the other approved VEGFR TKIs, the drug is a highly potent and selective VEGFR inhibitor.